JAN 22, 2017 10:04 AM PST

Moth gut microbe makes antibiotic

WRITTEN BY: Kerry Evans

Can insects get infected with bacteria?

 

Sure they can, but it doesn’t happen all that often. That fact sparked the interest of researchers at Zhejiang University and the Max Planck Institute for Chemical Ecology.

 

The cotton leafworm, Spodoptera littoralis, is a moth, and its larvae love to munch on plants. Bacteria also hang out on plants, and the larvae inevitably ingest them. The odd thing is that these bacteria don’t seem to make the little larvae sick.

 

Spodoptera littoralis larva

 

This led Yongqi Shao and Wilhelm Boland to look at the larvae’s gut bacteria - maybe their microbiome was helping to keep them healthy?

 

They found that the composition of gut bacteria changes as these little insects grow up. Younger larvae have many virulent Enterococcus species in their guts, but older larvae have the nonpathogenic E. mundtii. According to Shao, "we show that the evolutionary success of insects is partially based on a symbiotic association with gut microbes, which co-evolved with their hosts over millions of years."

 

The group Isolated various species of Enterococcus from the larvae and determined how they competed with each other. What they found was quite surprising - E. mundtii inhibited the growth of other bacteria! How, exactly? They showed that E. mundtii secretes a bacteriocin (an antimicrobial peptide) that they called mundticin KS. Bacteriocins are small proteins made by bacteria to inhibit the growth of other closely related bacteria.

 

In their first experiment, they showed that something in the E. mundtii culture supernatant (later identified as mundticin KS) was able to inhibit the growth of E. faecalis or E. casseliflavus. It did not inhibit the growth of other E. mundtii cells - it is immune to the mundticin that it produces.

 

Shao and Boland went on to test if mundticin could cure larvae of a bacterial infection. They purified mundticin and infected the larvae with a high dose of E. faecalis. Sure enough, larvae that had E. mundtii in their guts, that also made mundticin, were cured of the infection.

 

According to Boland, “the antimicrobial promotes symbiosis by providing a competitive advantage for E. mundtii, contributing to its dominance in the gut microbiome, while protecting the cotton leafworm against pathogens. We expect that protective associations with antibiotic-producing bacteria is a common strategy of insects against microbial invaders."

 

The next step is to look for similar antimicrobial mechanisms in other insect species. Such systems could be exploited by the agriculture industry to protect crops from pathogens. These peptides could also be useful to human health, where some suggest they could be used as food preservatives.

 


Source: Cell Chemical Biology, EurekAlert

About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
JUL 19, 2018
Cardiology
JUL 19, 2018
HIV Infection Doubles Risk of Heart Disease
Recent study of 150 countries and over 800,000 people shows HIV patients are more than twice as likely to develop Heart Disease than uninfected individuals....
AUG 10, 2018
Videos
AUG 10, 2018
Can the Black Death Make a Comeback?
The bacterium that causes plague was never wiped out....
AUG 13, 2018
Immunology
AUG 13, 2018
Silent Viruses Impact Microbe and Immune Cell Populations
Subclinical infections may alter the immune system and gut microbiota in the human host impacting how we respond to environmental stimuli like vaccines....
AUG 31, 2018
Microbiology
AUG 31, 2018
An Ebola Outbreak in the Democratic Republic of Congo
In August, the World Health Organization declared that an Ebola outbreak was happening in the DRC....
SEP 04, 2018
Drug Discovery
SEP 04, 2018
'Fosfomycin' Antibiotic Treatment to Combat Listeria Infections
Antibiotic-resistant bacteria that were long thought to be untreatable may now be treated with a powerful antibiotic according to a recent study published ...
SEP 26, 2018
Immunology
SEP 26, 2018
What Superbug? A New Antibiotic Contender
Scientists from a biotechnology corporation, Genentech, have altered a protein that blocks a signaling pathway in gram-negative bacteria to engineer a new antibiotic, currently called G0775,...
Loading Comments...